Dr. Bernd Timmermann
Dr. Bernd Timmermann
Sequencing Core Facility
Telefon:+49 30 8413-1777

Email: /


Esrrb Unlocks Silenced Enhancers for Reprogramming to Naïve Pluripotency.
Collaboration project with MPI for Molecular Biomedicine published in Cell Stem Cell.
June 14, 2018

Illumina NovaSeq 6000 platform installed.
New production-scale sequencing system at the MPI-MG is up and running.
Jan 31, 2018

Invitation to the 10th anniversary party of the Max Planck Sequencing Core Facility.
Ten years after the establishment of our unit, we would like to invite you to join us on Thursday 11th of January at 4pm at our office rooms, for a celebration of the group’s achievements over the decade.
Jan 1, 2018

Chromium Controller from 10x Genomics installed. New high-throughput single cell analysis platform at the MPI-MG is up and running.
Dec 8, 2017

Protein interaction perturbation profiling at amino-acid resolution.
New paper in Nature Methods.
Oct 16, 2017

Hexaploid sweet potato genome decoded.
New paper in Nature Plants.
Aug 21, 2017

Servicegruppe "Sequenzierung"

Header image 1357296896


New sequencing technologies are currently revolutionizing the field of genomic research. They enable researchers to investigate (epi)genomes and transcriptomes at an unexampled depth and level of detail.
Founded in 2007 the Next Generation Sequencing (NGS) Group at the Max Planck Institute for molecular Genetics (MPIMG) is a central unit which provides its service to all research groups of the institute. Since 2010 the expertise is also provided to scientists outside the MPIMG and the group acquired the status of a Sequencing Core Facility for all institutes of the biological-medical section (BMS) of the Max Planck Society.
The Sequencing Core Facility operates several next generation sequencers and maintains a fully equipped lab and staff able to perform a variety of sequencing applications - from sample preparation to data analysis. The NGS unit was founded to help researchers process DNA and RNA samples in an efficient and economical manner. We established automation solutions for the sample preparation to increase the throughput and minimize technical variation (Beckmann Spri-Te and 384 Beckman Multimek pipetting systems). By centralizing equipment and expertise, we have dramatically reduced the overall expense to the society, while increasing the efficiency and quality of the data generated. Currently we are providing expertise for two different technical platforms: Roche/454 FLX+ and Illumina Hiseq 2000/NextSeq 500 systems. At a read length of up to 1000 bases (modal read length around 800 bases) the 454 technology offers a great benefit especially for de novo genome sequencing, metagenome analysis, full length transcriptome analysis and amplicon sequencing. The high throughput of our Illumina systems in terms of Gigabases produced per run completes our sequencing service and offers a real advantage for many applications. Expression profiling (RNA-Seq), methylation analysis (MeDIP-Seq and Bisulphite-Seq), copy number analysis as well as the identification of protein binding sides (ChIP-Seq) and the analysis of whole exomes or genomes profite from the high output of this system to a great extent.

loading content
Zur Redakteursansicht